<DOC>
	<DOC>NCT02354274</DOC>
	<brief_summary>To investigate the effect of escalation of radiation dose to tumor and lymph nodes based on an inhomogeneous dose distribution controlled by FDG-PET positive areas compared to a standard homogeneous dose spread</brief_summary>
	<brief_title>Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant NavelbineÂ®</brief_title>
	<detailed_description />
	<mesh_term>Vinorelbine</mesh_term>
	<criteria>Patients with histologically or cytologically proven locally advanced NSCLC stage IIB to IIIB Performance status 01 Able to comply with treatment and follow study and followup procedures Women must have negative pregnancy test Signed, informed consent Plan for radiotherapy with conventional 66 Gy/ 33 F, which meets all dosing limits two normal tissue must be available Any unstable systemic disorder (including infection , unstable angina, congestive heart failure , severe liver , kidney or metabolic disease) Need for nasal oxygen Former thoracic radiotherapy, unless there is no significant overlap with previous fields Any other active malignant disease Unable to take oral medications or needing intravenous nutrition Ulcer Nursing women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>